| Raegan Mae Stanley, SLP | |
|
650 N Shoreline Dr, Wasilla, AK 99654-6677 | |
| (907) 376-6363 | |
| (907) 376-6366 |
| Full Name | Raegan Mae Stanley |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 650 N Shoreline Dr, Wasilla, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053761437 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP-838 (Wyoming) | Secondary |
| 235Z00000X | Speech-language Pathologist | 144512 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Raegan Mae Stanley, SLP 650 N Shoreline Dr, Wasilla, AK 99654-6677 Ph: (907) 376-6363 | Raegan Mae Stanley, SLP 650 N Shoreline Dr, Wasilla, AK 99654-6677 Ph: (907) 376-6363 |
News Archive
Pulmonx, an emerging leader in interventional pulmonology, announced today that the New England Journal of Medicine has published the results of the largest prospective, randomized, controlled study completed to date of endobronchial approaches to emphysema treatment, the VENT Study (Endobronchial Valve for Emphysema PalliatioN Trial).
Products from the Massachusetts pharmacy linked to the deadly meningitis outbreak passed a lab test in May, reports The Wall Street Journal. In addition, the pharmacy dodged a reprimand by Massachusetts regulators in 2004 after protesting it would be "fatal to the business." The company's founders come under scrutiny by media outlets as more people file lawsuits.
It's the most common bacteria-related sexually transmitted disease in the United States, so researchers at The University of Texas at San Antonio's South Texas Center for Emerging Infectious Diseases (STCEID) and The University of Texas at San Antonio Health Science Center have partnered to discover a vaccine that will prevent Chlamydia.
Igenica, Inc., a leading biopharmaceutical company focused on the discovery and development of first-in-class antibodies, today announced that it has raised $33 million in a Series C round of funding.
Accumulation of water in the lungs (lungcongestion) is a common condition in hemodialysis patients, particularly in those at high cardiovascular risk, like those presenting coronary artery disease and/or heart failure.
› Verified 3 days ago
Rhonda Price Burt, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 950 E Bogard Rd Ste 228, Wasilla, AK 99654 Phone: 907-376-8938 | |
Katherine Elaine Mclarnon, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1051 E Bogard Rd Ste 1, Wasilla, AK 99654 Phone: 907-521-4566 | |
Christine Anne Samms, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3505 E Meridian Park Loop Ste 200, Wasilla, AK 99654 Phone: 907-357-4543 | |
Mrs. Regina Marie Jones, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 W Swanson Ave, Wasilla, AK 99654 Phone: 907-313-3600 | |
Mrs. Carol Anne Reed, MS, CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 401 E Bogard Rd, Wasilla, AK 99654 Phone: 907-357-2578 Fax: 907-357-2529 | |
Sarah Moriarty, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 613 S Knik Goose Bay Rd Ste B, Wasilla, AK 99654 Phone: 888-698-9881 |